Dandelion Root
Dandelion Root, licence 80074164: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Wing Quon NHP Production Inc.
- NPN or DIN-HM
- 80074164
- Status
- Active licence
- Licence date
- 1 December 2016
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Taraxacum officinale Source : Racine Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 1600.0 milligramme | 400.0 milligramme | Not calculated |
| Taraxacum officinale Source : Racine | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose, Stéarate de magnésium, Gélatine, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2.0 Capsule ; maximum: 3.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Traditionally used to stimulate appetite and to increase bile flow.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use product during pregnancy and breastfeeding; Do not take if allergic to Asteraceae (daisy family) plants; Do not use if you have Gibert's syndrome or Crigler-Najjar syndrome; Do not use if you have gall bladder inflammation, bile duct obstruction, or intestinal blockage; Do not use if you have bile duct cancer, pancreatic cancer, haemolytic anemia, intestinal spasm, liver cancer or liver disease.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are on diabetes medication; If you are taking prescription medications, consult a health care practitioner prior to use; Consult a health care practitioner prior to use if you are taking psychoactive medication; Discontinue use if hypersensitivity occurs such as contact dermatitis; If symptoms persist, consult a health care practitioner. If symptoms worsen, consult a health care practitioner. If you have heart disease, high or low blood pressure, kidney disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics, do not use this product.
Source
Official Health Canada record, licence 80074164
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.